Clinical trials sponsored by Cancer Research UK
8
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 3Phase 2 8Phase 3 5
Conditions studied
Recruiting trials led by Cancer Research UK
- A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
- DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- HTL0039732 in Participants With Advanced Solid Tumours
- TT-702 in Patients With Advanced Solid Tumours.
Common questions
How many trials is Cancer Research UK recruiting for?
Cancer Research UK is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.